Hip Pain ChronicLund LHGPNCT03490071
Long-term Follow up of Patients With Longstanding Hip and Groin Pain
An observational study of Hip Pain Chronic, run by Lund University at 1 site in Sweden.
Trial summary
In this longitudinal cohort study including young to middle aged people with longstanding hip and groin pain (LHGP) referred to tertiary care, we will collect data of patient reported symptoms, function and quality of life three and seven years after the initial contact with orthopedic surgeon. Read more about this study
- Who is it for?
- Ages 18 to 55 years
- Conditions the study is for
- Hip Pain Chronic
- How many people
- 58 participants
- Where
- 1 siteSweden
- Study dates
- 1 Jan 2018to 31 Dec 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 55 years
- All sexes
- Adult
Study population: Patients will be recruited from the Department of Orthopedics, Skåne University Hospital, Sweden.
Who may be able to join
- Unilateral or bilateral hip/groin pain >3 months
- Age 18-55 years
- No previous hip surgery
Who cannot join
- Hip pathology (i.e., Perthes' disease)
- Verified moderate or severe osteoarthritis (OA) (Tönnis grade >1)
- Palpable hernia
- Low-back pain with a positive Lasègue test
- MRI-verified lower back/spine pathology (i.e., spinal stenosis, disc herniation)
- Other musculoskeletal co-morbidities overriding the hip-related symptoms and dysfunction
Show all 10Show fewer
- Co-morbidities excluding physical activity and training
- Psycho-social disorders
- Drug abuse
- Not understanding the language of interest.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Three and Seven Year Follow-up of Patients Reported Symptoms, Function and Quality of Life in Patients With Longstanding Hip and Groin Pain Referred to Tertiary Care. A Longitudinal Study
In this longitudinal cohort study including young to middle aged people with longstanding hip and groin pain (LHGP) referred to tertiary care, we will collect data of patient reported symptoms, function and quality of life three and seven years after the initial contact with orthopedic surgeon.
Read the detailed description
81 physically active patients (18-55 years) with (LHGP) who were enrolled in a cross-sectional study (Diagnosis and functional limitations in the young to middle-aged physically active population with long-standing hip/groin pain: A cross-sectional study) during the period October 2014 to January 2017 will be recruited to this longitudinal cohort study.
A research coordinator will contact the patients and provide them with written and oral information about the study. Patients who accept to participate will electronically complete the following questionnaires. The same questionnaires were included at baseline, i.e., in the cross-sectional study.
- Copenhagen Hip and Groin Outcome Score (HAGOS)
- HSAS - Hip Sports Activity Scale (HSAS)
- Patient Specific Functional Scale
- Medical Outcomes Study short form 36 (SF-36)
- K-10 questionnaire
- Self-Presentation in Exercise Questionnaire (SPEQ)
- Multidimensional Scale of Perceived Social Support (MSPSS)
Additional questions about treatment, medication, patient satisfaction and perceived change in hip function will be included.
For descriptive purposes, the mean difference (95% CI), or median (quartiles), between baseline and follow-up assessments will be used as appropriate. Separate linear regression models will be used to evaluate the change in each variable compared to baseline values.
- Conditions
- Hip Pain Chronic
- Keywords
- Longstanding hip and groin pain, Patient reported outcome
What is being measured
The primary outcome is the main question the study is designed to answer.
Changes in the Copenhagen Hip and Groin Outcome Score (HAGOS)
Patient reported outcome regarding hip dysfunction, which includes six subscales; pain, symptoms, physical function in daily living, physical function in sport and recreation, participation in physical activity, and quality of life. The score for each subscale ranges from 0-100, where 0 indicates extreme problems and 100 no problems. Patient Acceptable Symptom State (PASS) will be derived from HAGOS score using previously described cut-off values for the different subscales
Measured: 3 and 7 years after baseline (cross-sectional study)
Secondary outcomes (6)
HSAS - Hip Sports Activity Scale (HSAS)
Patient reported outcome regarding activity level. The scale ranges från 0-8 where 0 indicates the lowest activity and 8 the highest.
Measured: 3 and 7 years after baseline (cross-sectional study)
K-10 questionnaire
Patient reported outcome regarding mental health. This instrument consists of 10 questions, where each question is scored from 1 to 5. The total score is summerized and ranges from 10 to 50, where 10 indicates no problem and 50 severe problems.
Measured: 3 years after baseline (cross-sectional study)
Self-Presentation in Exercise Questionnaire (SPEQ)
Patient reported outcome regarding self image during exercise and consists of 14 questions. Each question is assessed on a 6-point Likert-type scale ranging from 1 (strongly disagree) to 6 (strongly agree). Higher scores represent a greater desire to present oneself as an exerciser and a greater use of strategies to portray oneself as an exerciser.
Measured: 3 years after baseline (cross-sectional study)
The Multidimensional Scale of Perceived Social Support (MSPSS)
The Multidimensional Scale of Perceived Social Support (MSPSS) is designed to measure perceptions of support from 3 sources: Family, Friends, and a Significant Other. The scale is comprised of a total of 12 items, with 4 items for each subscale. The items are scored on 7 point likert scale anging from 1 (very strongly disagree) to 7 (very strongly agree). The mean value tor each subscale are calculated. High score indicates a percetion of good social support.
Measured: 3 years after baseline (cross-sectional study)
Medical Outcomes Study short form 36 (SF-36)
Patient reported outcome regarding general health, which includes eight subscales; vitality, physical functioning, bodily pain, general health perception, physical role functioning, emotional role functioning, social role functioning and mental health. The score for each subscale ranges from 0-100, where 0 indicates extreme problems and 100 no problems.
Measured: 3 and 7 years after baseline (cross-sectional study)
Additional questions regarding treatment, medication, patient satisfaction and perceived change in hip function.
Additional questions about treatment, medication, patient satisfaction and perceived change in hip function will be included for descriptive purpose.
Measured: 3 and 7 years after baseline (cross-sectional study)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Apr 2018
- Study start1 Jan 2018
- Primary completion1 Mar 2024
- Study completion31 Dec 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Hip Pain ChronicStudies of the same condition, open and under way.
- More trials run by Lund UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 58 participants (actual)
Sponsor and investigators
- Lead sponsor
- Lund University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Eva Ageberg, PhD, Principal investigator, Lund University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03490071
- Sponsor's protocol ID
- Lund LHGP
- Acronym
- Lund LHGP
- Status last verified
- Feb 2024
- First submitted
- 28 Mar 2018
- Last updated
- 15 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 15 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Three and Seven Year Follow-up of Patients Reported Symptoms, Function and Quality of Life in Patients With Longstanding Hip and Groin Pain Referred to Tertiary Care. A Longitudinal Study
- ClinicalTrials.gov ID
- NCT03490071
- Acronym / sponsor ID
- Lund LHGP / Lund LHGP
- Conditions
- Hip Pain Chronic
- Keywords
- Longstanding hip and groin pain, Patient reported outcome
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 58 participants (actual)
- Lead sponsor
- Lund UniversityUniversity, hospital or other
- Study start
- 1 Jan 2018 (actual)
- Primary completion
- 1 Mar 2024 (actual)
- Study completion
- 31 Dec 2024 (actual)
- First posted
- 6 Apr 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In this longitudinal cohort study including young to middle aged people with longstanding hip and groin pain (LHGP) referred to tertiary care, we will collect data of patient reported symptoms, function and quality of life three and seven years after the initial contact with orthopedic surgeon.
Detailed description
81 physically active patients (18-55 years) with (LHGP) who were enrolled in a cross-sectional study (Diagnosis and functional limitations in the young to middle-aged physically active population with long-standing hip/groin pain: A cross-sectional study) during the period October 2014 to January 2017 will be recruited to this longitudinal cohort study.
A research coordinator will contact the patients and provide them with written and oral information about the study. Patients who accept to participate will electronically complete the following questionnaires. The same questionnaires were included at baseline, i.e., in the cross-sectional study.
- Copenhagen Hip and Groin Outcome Score (HAGOS)
- HSAS - Hip Sports Activity Scale (HSAS)
- Patient Specific Functional Scale
- Medical Outcomes Study short form 36 (SF-36)
- K-10 questionnaire
- Self-Presentation in Exercise Questionnaire (SPEQ)
- Multidimensional Scale of Perceived Social Support (MSPSS)
Additional questions about treatment, medication, patient satisfaction and perceived change in hip function will be included.
For descriptive purposes, the mean difference (95% CI), or median (quartiles), between baseline and follow-up assessments will be used as appropriate. Separate linear regression models will be used to evaluate the change in each variable compared to baseline values.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 55 years
- Sex
- All
- Age groups
- Adult
- Study population
- Patients will be recruited from the Department of Orthopedics, Skåne University Hospital, Sweden.
Key inclusion criteria (3 listed)
- Unilateral or bilateral hip/groin pain >3 months
- Age 18-55 years
- No previous hip surgery
Key exclusion criteria (10 listed)
- Hip pathology (i.e., Perthes' disease)
- Verified moderate or severe osteoarthritis (OA) (Tönnis grade >1)
- Palpable hernia
- Low-back pain with a positive Lasègue test
- MRI-verified lower back/spine pathology (i.e., spinal stenosis, disc herniation)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Changes in the Copenhagen Hip and Groin Outcome Score (HAGOS)
Time frame: 3 and 7 years after baseline (cross-sectional study)
Patient reported outcome regarding hip dysfunction, which includes six subscales; pain, symptoms, physical function in daily living, physical function in sport and recreation, participation in physical activity, and quality of life. The score for each subscale ranges from 0-100, where 0 indicates extreme problems and 100 no problems. Patient Acceptable Symptom State (PASS) will be derived from HAGOS score using previously described cut-off values for the different subscales
6 secondary outcomes
HSAS - Hip Sports Activity Scale (HSAS)
Time frame: 3 and 7 years after baseline (cross-sectional study)
K-10 questionnaire
Time frame: 3 years after baseline (cross-sectional study)
Self-Presentation in Exercise Questionnaire (SPEQ)
Time frame: 3 years after baseline (cross-sectional study)
The Multidimensional Scale of Perceived Social Support (MSPSS)
Time frame: 3 years after baseline (cross-sectional study)
Medical Outcomes Study short form 36 (SF-36)
Time frame: 3 and 7 years after baseline (cross-sectional study)
Additional questions regarding treatment, medication, patient satisfaction and perceived change in hip function.
Time frame: 3 and 7 years after baseline (cross-sectional study)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Apr 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Hip Pain Chronic
RecruitingPhase 4
PENG vs L-ESPB With S-ESPB for Analgesia in Total Hip Arthroplasty
Hip Osteoarthritis, Hip Arthropathy
Not yet recruiting
Hip Muscle Strengthening and Calf Myofascial Release in Females With Chronic Plantar Fasciitis
Chronic Planter Fascitis
Recruiting
Studying Melatonin and Recovery in Teens
Juvenile; Scoliosis, Scoliosis Idiopathic
Active, not recruiting
Developing an Opioid Taper Intervention Before Total Joint Arthroplasty
Arthritis Knee, Arthritis Hip
RecruitingObservational study
MDR - PMCF Study for Taperloc Complete Stems
Hip Arthritis, Hip Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Eva Ageberg, PhD principal investigator
Lund University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Hip Pain Chronic, run by Lund University at 1 site in Sweden.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Changes in the Copenhagen Hip and Groin Outcome Score (HAGOS) (time frame: 3 and 7 years after baseline (cross-sectional study)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Apr 2026.